Trials / Completed
CompletedNCT00895011
Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 298 (actual)
- Sponsor
- VIVUS LLC · Industry
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | One dose 30 minutes prior to initiation of sexual activity |
| DRUG | Avanafil | One dose 30 minutes prior to initiation of sexual activity |
| DRUG | Avanafil | One dose 30 minutes prior to initiation of sexual activity |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2009-05-07
- Last updated
- 2012-10-01
- Results posted
- 2012-06-28
Locations
51 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00895011. Inclusion in this directory is not an endorsement.